Correlation Between Day One and Cymabay Therapeu
Can any of the company-specific risk be diversified away by investing in both Day One and Cymabay Therapeu at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Cymabay Therapeu into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Cymabay Therapeu, you can compare the effects of market volatilities on Day One and Cymabay Therapeu and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Cymabay Therapeu. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Cymabay Therapeu.
Diversification Opportunities for Day One and Cymabay Therapeu
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Day and Cymabay is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Cymabay Therapeu in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cymabay Therapeu and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Cymabay Therapeu. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cymabay Therapeu has no effect on the direction of Day One i.e., Day One and Cymabay Therapeu go up and down completely randomly.
Pair Corralation between Day One and Cymabay Therapeu
If you would invest 1,183 in Cymabay Therapeu on October 26, 2024 and sell it today you would earn a total of 0.00 from holding Cymabay Therapeu or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 5.26% |
Values | Daily Returns |
Day One Biopharmaceuticals vs. Cymabay Therapeu
Performance |
Timeline |
Day One Biopharmaceu |
Cymabay Therapeu |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Day One and Cymabay Therapeu Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Day One and Cymabay Therapeu
The main advantage of trading using opposite Day One and Cymabay Therapeu positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Cymabay Therapeu can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cymabay Therapeu will offset losses from the drop in Cymabay Therapeu's long position.Day One vs. Surrozen | Day One vs. Armata Pharmaceuticals | Day One vs. Pasithea Therapeutics Corp | Day One vs. Aditxt Inc |
Cymabay Therapeu vs. Day One Biopharmaceuticals | Cymabay Therapeu vs. X4 Pharmaceuticals | Cymabay Therapeu vs. Inozyme Pharma | Cymabay Therapeu vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |